NCT02812810

Brief Summary

The fight against smoking is a public health priority. Without help, fewer than 5% of des smokers are abstinent at 12 months after smoking cessation. Despite well-managed attempts at smoking cessation with nicotine substitutes, the rate of success at 12 months in patients dependent on nicotine is only 18%. Moreover, other therapeutic strategies (acupuncture, hypnosis…) have not proved to be effective. The investigators propose a new therapeutic strategy for smoking cessation, which is based on associating nicotine substitutes (to reduce physical symptoms of weaning from nicotine) with rTMS at 1 Hz to the right DorsoLateral PreFrontal Cortex (DLPFC) for 2 weeks (to diminish craving for tobacco). The principal objective is to improve the success rate for smoking cessation attempts in patients who are highly dependent on nicotine, and who have failed using usual smoking cessation strategies.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 20, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2016

Completed
Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

3.4 years

First QC Date

June 20, 2016

Last Update Submit

February 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline score of Tabacco Craving Questionnaire (TCQ)

    at Week 0, Week 1, Week 2, Week 6 and Week 12 after stimulation

Study Arms (2)

active rTMS

EXPERIMENTAL
Device: active rTMS

placebo rTMS

PLACEBO COMPARATOR
Device: sham rTMS

Interventions

sham rTMSDEVICE
placebo rTMS
active rTMS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult 18-65 years old
  • Wishing to stop smoking
  • Highly dependent on nicotine (score ≥ 7 on the Fagerström self-questionnaire)
  • History of at least 2 failed attempts to stop smoking despite recommended treatments (nicotine, vareniciline, bupropion)

You may not qualify if:

  • Abstinence in the 3 previous months
  • Absence of effective contraception for women
  • Progressive chronic disease
  • Ongoing psychiatric disorders
  • Current addiction to other substances or cessation of less than one year
  • Current treatment with psychotropic agents
  • Epilepsy and other contra-indications for rTMS (pacemaker, metallic clips or other electronic implants, head trauma, intracranial hypertension).
  • Contra-indications for transdermal nicotine substitutes (recent myocardial infarction, unstable or worsening angina, Prinzmetal angina, severe heart rhythm disorders, recent stroke, skin disorders that could interfere with the use of transdermal treatments, hypersensitivity to one of the constituents).
  • Personnel working in the psychiatric and addictology unit of the CHU (conflict of interest)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire

Dijon, 21079, France

Location

Related Publications (1)

  • Trojak B, Meille V, Achab S, Lalanne L, Poquet H, Ponavoy E, Blaise E, Bonin B, Chauvet-Gelinier JC. Transcranial Magnetic Stimulation Combined With Nicotine Replacement Therapy for Smoking Cessation: A Randomized Controlled Trial. Brain Stimul. 2015 Nov-Dec;8(6):1168-74. doi: 10.1016/j.brs.2015.06.004. Epub 2015 Jun 16.

MeSH Terms

Conditions

Smoking CessationBehavior, Addictive

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorCompulsive BehaviorImpulsive Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2016

First Posted

June 24, 2016

Study Start

September 1, 2011

Primary Completion

February 1, 2015

Last Updated

February 6, 2026

Record last verified: 2026-02

Locations